Loss of KCNQ1 has been reported to exert anti‐tumor functions via promoting epithelial‐to‐mesenchymal transition (EMT) and disrupting adheren junctions in epithelial cancers.50 The gene discussed is KCNQ1; the disease is neoplasm.